Patents by Inventor Stephen Story

Stephen Story has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8574642
    Abstract: The present invention relates to methods and formulations directed to the management of Cathepsin G, Cathepsin S, Cathepsin B, Cathepsin L, Butyryl Cholinesterase, Peptidase HIV-1, and NF-kB enzymes comprising the administration of processed Morinda citrifolia based formulations.
    Type: Grant
    Filed: November 21, 2006
    Date of Patent: November 5, 2013
    Assignee: Tahitian Noni International, Inc.
    Inventors: Afa Kehaati Palu, Chen Su, Bing-Nan Zhou, Brett West, Claude Jarake Jensen, Stephen Story
  • Patent number: 8535741
    Abstract: This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plant Morinda cirtrifolia to individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf Moreover, the foregoing formulations result in alleviating pain and inflammation.
    Type: Grant
    Filed: September 27, 2011
    Date of Patent: September 17, 2013
    Assignee: Morinda, Inc.
    Inventors: Bing-Nan Zhou, Chen Su, Afa K. Palu, Brett J. West, Shixin Deng, Claude Jarakae Jensen, Stephen Story
  • Publication number: 20130079380
    Abstract: This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plant Morinda cirtrifolia to individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf Moreover, the foregoing formulations result in alleviating pain and inflammation.
    Type: Application
    Filed: September 27, 2011
    Publication date: March 28, 2013
    Inventors: Bing-Nan Zhou, Chen Su, Afa K. Palu, Brett J. West, Shixin Deng, Claude Jarakae Jensen, Stephen Story
  • Publication number: 20120237626
    Abstract: The present invention comprises methods and compositions for improving profiles of lipid proteins, reducing low-density lipoprotein levels, increasing high-density lipoprotein levels, decreasing the absorption of fatty acids across the intestinal epithelium and inhibiting HMG-CoA Reductase in living organisms utilizing Morinda citrifolia L activity in mammals, including humans.
    Type: Application
    Filed: January 13, 2005
    Publication date: September 20, 2012
    Inventors: Afa Palu, Claude Jensen, Mian Wang, Bing-Nan Zhou, Stephen Story
  • Patent number: 8025910
    Abstract: This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plant Morinda cirtrifolia to individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf. More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf. Moreover, the foregoing formulations result in alleviating pain and inflammation.
    Type: Grant
    Filed: May 10, 2007
    Date of Patent: September 27, 2011
    Assignee: Tahitian Noni International, Inc.
    Inventors: Bing-Nan Zhou, Chen Su, Afa K. Palu, Brett J. West, Shixin Dong, Claude Jarake Jensen, Stephen Story
  • Publication number: 20090053341
    Abstract: The present invention is directed to methods of inhibiting Aromatase or Aromatase enzymes that function to convert androgens to estrogens, inhibiting receptors from binding with estrogen, and reducing and/or regulating estrogen production, as well as reducing the amount of estrogen produced within the body and regulating such production. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration.
    Type: Application
    Filed: August 21, 2007
    Publication date: February 26, 2009
    Inventors: Afa Kehaati Palu, Brett West, Claude Jarake Jensen, Chen Su, Bing-Nan Zhou, Stephen Story
  • Publication number: 20090022828
    Abstract: The present invention relates to medicinal products, as well as to health and wellness food products, and particularly to a medicinal product or a health and wellness food product for inhibiting Angiotensin Converting Enzyme and Chymase enzyme pathways.
    Type: Application
    Filed: July 16, 2007
    Publication date: January 22, 2009
    Inventors: Afa Kehaati Palu, Chen Su, Bing-Nan Zhou, Stephen Story, Claude Jarake Jensen
  • Publication number: 20090022830
    Abstract: Methods and compositions relating to leaf extracts obtained from removing liquids from relatively dry Morinda citrifolia leaves. Methods and compositions relating to a leaf serum created from combining leaf extract and fruit juice from the Morinda citrifolia L. plant. Methods and compositions relating to leaf extract compositions comprising one or more of the leaf extracts and leaf serums.
    Type: Application
    Filed: July 17, 2007
    Publication date: January 22, 2009
    Inventors: Afa Kehaati Palu, Chen Su, Bing-Nan Zhou, Stephen Story, Claude Jarake Jensen
  • Publication number: 20080213415
    Abstract: The present invention relates to methods and formulations directed inhibiting carbonic anhydrase, fatty acid amide hydrolase and endothelin-converting enzymes comprising the administration of processed Morinda citrifolia based formulations.
    Type: Application
    Filed: February 7, 2008
    Publication date: September 4, 2008
    Inventors: Afa K. Palu, Claude Jarake Jensen, Brett J. West, Stephen Story
  • Publication number: 20080206376
    Abstract: The present invention relates to medicinal products, as well as to health and wellness food products, and particularly to a medicinal product or a health and wellness food product for inhibiting Angiotensin Converting Enzyme and Chymase enzyme pathways.
    Type: Application
    Filed: February 22, 2007
    Publication date: August 28, 2008
    Inventors: Afa Kehaati Palu, Chen Su, Bing-Nan Zhou, Claude Jarakae Jensen, Stephen Story
  • Publication number: 20070286910
    Abstract: This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plant Morinda cirtrifolia to individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf. More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf. Moreover, the foregoing formulations result in alleviating pain and inflammation.
    Type: Application
    Filed: May 10, 2007
    Publication date: December 13, 2007
    Inventors: Bing-Nan Zhou, Chen Su, Afa Palu, Brett West, Shixin Dong, Claude Jensen, Stephen Story
  • Publication number: 20070281903
    Abstract: The present invention is directed to methods and formulations for inhibiting Lipoxygenase enzymes that function to biosynthesize or metabolize arachidonic acid into its intermediate Leukotriene constituents, as well as a method and formulation for treating and preventing diseases, including inflammatory diseases, and the symptoms associated with such diseases. The present invention methods and formulations effectively function as such through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration, wherein the processed Morinda citrifolia product may comprise one or more isolated active ingredients.
    Type: Application
    Filed: August 21, 2007
    Publication date: December 6, 2007
    Inventors: Afa Palu, Brett West, Claude Jensen, Chen Su, Bing-Nan Zhou, Stephen Story
  • Publication number: 20070259060
    Abstract: The present invention advances prior art techniques, formulations, and methods for treating mammary breast cancer during its initial phases, as well as for preventing mammary breast cancer, by providing a safe, nutraceutical formulation comprising Morinda citrifolia, methylsulfonylmethane (MSM), and other ingredients.
    Type: Application
    Filed: April 27, 2007
    Publication date: November 8, 2007
    Inventors: Mian-Ying Wang, Claude Jensen, Chen Su, Stephen Story
  • Publication number: 20070248701
    Abstract: Methods and formulations for using Tahitian Noni juice for inhibiting naturally occurring phosphodiesterases (PDEs).
    Type: Application
    Filed: May 18, 2007
    Publication date: October 25, 2007
    Inventors: Chen Su, Afa Palu, Bing-Nan Zhou, Claude Jensen, Stephen Story
  • Publication number: 20070218146
    Abstract: The present invention relates to methods, compositions and their constituents for inhibiting 5-Lipoxygenase (5-LO), 15-Lipoxygenase (15-LO), cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), in living organisms. More particularly, the present invention relates to methods and compositions involving the inhibition of 5-Lipoxygenase (5-LO), 15-Lipoxygenase (15-LO), cyclooxygenase-l (COX-1) and cyclooxygenase-2 (COX-2), using processed Mortinda citrifolia L. plant products.
    Type: Application
    Filed: March 6, 2007
    Publication date: September 20, 2007
    Inventors: Afa Palu, Claude Jensen, Mian Wang, Bing-Nan Zhou, Stephen Story
  • Patent number: 7264829
    Abstract: Methods and compositions relating to leaf extracts obtained from Morinda citrifolia leaves. Methods and compositions relating to a leaf serum created from combining leaf extract and fruit juice from the Morinda citrifolia L. plant. Methods and compositions relating to leaf extract compositions comprising one or more of the leaf extracts and leaf serums.
    Type: Grant
    Filed: March 8, 2004
    Date of Patent: September 4, 2007
    Assignee: Tahitian Noni International, Inc.
    Inventors: Bing-Nan Zhou, Afa Kehaati Palu, Chen X. Su, Claude Jarakae Jensen, Stephen Story
  • Publication number: 20070202206
    Abstract: A method and composition for inhibiting certain enzymes, where such inhibition results in various health benefits is provided. More particularly, a method and composition using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf to inhibit the following: HMG-CoA Reductase; Phosphodiesterases (3 and 4) PDE3 and PDE4; 5-Lipoxygenase (LOX) and 15-LOX; Xanthine Oxidase (XO); Gamma Amino Butyric Acid (GABA) and the growth of the second most common human skin cancer cell line, is provided. Moreover, the foregoing enzymatic inhibitions result in: alleviating pain and inflammation; treating prostate cancers; lowering cholesterol levels; counteracting Diabetes Type II; maintaining the highest possible integrity of cellular interactions in the brain resulting in an undisturbed neural function, (i.e.
    Type: Application
    Filed: November 16, 2006
    Publication date: August 30, 2007
    Inventors: Afa Palu, Bing-Nan Zhou, Chen Su, Claude Jensen, Brett West, Stephen Story
  • Publication number: 20070196524
    Abstract: The present invention provides a formulation which may be utilized in agricultural practice that is eco-friendly and effective as plant growth promotion agent, soil improvement agent, bactericide and insecticide agent, disease and harmful insect prevention agent, and is suitable for organic farming. The formulation of the present invention is comprised of a Morinda citrifolia product or extract. The formulation of the present invention may be applied to fruit vegetables, leafy vegetables, root vegetables, grains as well as flowers and shrubs, increasing the amount of yield and extending freshness period after harvest. Further, the present invention relates to antifungal and antibacterial activity of processed Morinda citrifolia products, as well as from various fractions of extracts from these processed products and the Morinda citrifolia L. plant, and related methods to determine mean inhibitory concentrations.
    Type: Application
    Filed: April 26, 2007
    Publication date: August 23, 2007
    Inventors: Fumiyuki Isami, John Wadsworth, Scott Gerson, Afa Palu, Bing-Nan Zhou, Chen Su, Claude Jensen, Stephen Story
  • Publication number: 20070184137
    Abstract: The present invention relates to methods and formulations directed to the management of various Matrix Metalloproteinases enzymes comprising the administration of processed Morinda citrifolia based formulations.
    Type: Application
    Filed: November 28, 2006
    Publication date: August 9, 2007
    Inventors: Afa Palu, Johannes Westendorf, Brett West, Bing-Nan Zhou, Claude Jensen, Stephen Story
  • Publication number: 20070184135
    Abstract: The present invention is directed to methods and formulations for inhibiting Lipoxygenase enzymes that function to biosynthesize or metabolize arachidonic acid into its intermediate Leukotriene constituents, as well as a method and formulation for treating and preventing diseases, including inflammatory diseases, and the symptoms associated with such diseases. The present invention methods and formulations effectively function as such through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration, wherein the processed Morinda citrifolia product may comprise one or more isolated active ingredients.
    Type: Application
    Filed: June 7, 2004
    Publication date: August 9, 2007
    Inventors: Afa Palu, Bing-Nan Zhou, Chen Su, Claude Jensen, Stephen Story, Kim Asay